Eliron Amir

Chief Product Officer at Nucleai
  • Claim this Profile
Contact Information
Location
Israel, IL

Topline Score

Bio

Generated by
Topline AI

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.
You need to have a working account to view this content. Click here to join now

Experience

    • India
    • Software Development
    • Chief Product Officer
      • Jan 2018 - Present

      The company is a leading provider of an AI-powered precision oncology platform transforming biomarker discovery and treatment decisions. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy, and improving patient care. Nucleai works with leading pharmaceutical companies, licensing its research platform for internal use, and collaborating in biomarkers discovery projects. We believe in hard teamwork of bright and devoted people who are continually improving both as individuals and as a company. We are Team Nucleai Show less

    • CTO
      • 2014 - 2017

      Building AR based navigation system for lung cancer diagnosis. Building AR based navigation system for lung cancer diagnosis.

    • Israel
    • Armed Forces
    • 700 & Above Employee
    • AI Research Group Leader
      • 2011 - 2013

    • Algorithm Team Leader
      • 2010 - 2011

    • Algorithm Developer
      • 2007 - 2010

Education

  • Technion - Israel Institute of Technology
    Master of Science (MSc), Electrical and Electronics Engineering
    2008 - 2012
  • Technion - Israel Institute of Technology
    Bachelor of Science (BSc), Electrical and Electronics Engineering
    2002 - 2006
  • Technion - Israel Institute of Technology
    Bachelor of Arts (B.A.), Physics
    2002 - 2006

Community

You need to have a working account to view this content. Click here to join now